본문 바로가기

Jakyak-gamcho-tang, a decoction of Paeoniae Radix and Glycyrrhizae Radix et Rhizoma, ameliorates dexamethasone-induced muscle atrophy and muscle dysfunction

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
PHYTOMEDICINE123 · 2024
피인용
Web of Science 26Scopus 28
FWCI (Scopus)
3.82
JCR IF
JCR 2023 6.7
ISSN
0944-7113

저자

  1. Kim, Aeyung제1저자Korea Inst Oriental Med, KM Applicat Ctr, Daegu 41062, South Korea
  2. Kim, Yu RiKorea Inst Oriental Med, KM Convergence Res Div, Daejeon 305811, South Korea
  3. Park, Sang-MinKorea Inst Oriental Med, KM Data Div, Daejeon 34054, South Korea
  4. 이해승Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea
  5. Park, MusunKorea Inst Oriental Med, KM Data Div, Daejeon 34054, South Korea
  6. Yi, Jin-MuKorea Inst Oriental Med, KM Convergence Res Div, Daejeon 305811, South Korea
  7. Cha, Seongwon교신저자Korea Inst Oriental Med, KM Data Div, Daejeon 34054, South Korea
  8. Kim, No Soo교신저자Korea Inst Oriental Med, KM Convergence Res Div, Daejeon 305811, South Korea

초록

Background: Although chronic treatment with glucocorticoids, such as dexamethasone, is frequently associated with muscle atrophy, effective and safe therapeutics for treating muscle atrophy remain elusive. Jakyak-gamcho-tang (JGT), a decoction of Paeoniae Radix and Glycyrrhizae Radix et Rhizoma, has long been used to relieve muscle tension and control muscle cramp-related pain. However, the effects of JGT on glucocorticoid-induced muscle atrophy are yet to be comprehensively clarified. Purpose: The objective of the current study was to validate the protective effect of JGT in dexamethasone-induced muscle atrophy models and elucidate its underlying mechanism through integrated in silico – in vitro – in vivo studies. Study design and Methods: Differential gene expression was preliminarily analyzed using the RNA-seq data to determine the effects of JGT on C2C12 myotubes. The protective effects of JGT were further validated in dexamethasone-treated C2C12 myotubes by assessing cell viability, myotube integrity, and mitochondrial function or in C57BL/6 N male mice with dexamethasone-induced muscle atrophy by evaluating muscle mass and physical performance. Transcriptomic pathway analysis was also performed to elucidate the underlying mechanism. Results: Based on preliminary gene set enrichment analysis using the RNA-seq data, JGT regulated various pathways related to muscle differentiation and regeneration. Dexamethasone-treated C2C12 myotubes and muscle tissues of atrophic mice displayed substantial muscle protein degradation and muscle loss, respectively, which was efficiently alleviated by JGT treatment. Importantly, JGT-mediated protective effects were associated with observations such as preservation of mitochondrial function, upregulation of myogenic signaling pathways, including protein kinase B/mammalian target of rapamycin/forkhead box O3, inhibition of ubiquitin-mediated muscle protein breakdown, and downregulation of inflammatory and apoptotic pathways induced by dexamethasone. Conclusion: To the best of our knowledge, this is the first report to demonstrate that JGT could be a potential pharmaceutical candidate to prevent muscle atrophy induced by chronic glucocorticoid treatment, highlighting its known effects for relieving muscle spasms and pain. Moreover, transcriptomic pathway analysis can be employed as an efficient in silico tool to predict novel pharmacological candidates and elucidate molecular mechanisms underlying the effects of herbal medications comprising diverse biologically active ingredients.

키워드

DexamethasoneHerbal medicineJakyak-gamcho-tangMuscle atrophyPathway analysisTranscriptomeSKELETAL-MUSCLEMYOSTATIN GENEGLUCOCORTICOIDSEXPRESSIONEXTRACTDAMAGECONSTITUENTSMECHANISMSATROGIN-1STRESS

식별자

Scopus EID
2-s2.0-85177577693
WoS UID
001121349400001